• 文献
    はじめに
    1) Yoon SS, Coit DG, Portlock CS, et al: The diminishing role of surgery in the treatment of gastric lymphoma. Ann Surg 2004; 240: 28-37.
  • [A] 胃悪性リンパ腫の診断
    ① 総論
    2) Wotherspoon AC, Doglioni C, Diss TC, et al: Regression of primary low-grade B-cell gastriclymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-7.
  • ③ 臨床病期診断
    3) Rohatiner A, d’Amore F, Coiffier B, et al: Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400.
    4) A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-94.
    5) Cheson BD, Pfistner B, Juweid ME, et al; The International Harmonization Project on Lymphoma:Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579-86.
  • [B] 胃 MALT リンパ腫の治療
    ② 放射線治療
    6) http://www.nccn.org/professionals/physician_gls/PDF/nhl.pdf
    7) Schechter NR, Yahalom J: Low-grade MALT lymphoma of the stomach: A review of treatment options. Int J Radiat Oncol Biol Phys 2000; 46: 1093-103.
    8) Tsang RW, Gospodarowics MK, Pintilie M, et al: Localized mucosa-associated lymphoid tissue lymphomatreated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003; 21: 4157-64.
    9) Mittal B, Wasserman TH, Griffith RC: Non-Hodgkin’s lymphoma of the stomach. Am J Gastroenterol 1983; 78: 780-7.
    10) Varsos G, Yahalom J: Alternatives in the management of gastric lymphoma. Leuk Lymph 1991; 4: 1-8.
    11) Maor M, North L, Cabanillas F, et al: Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma. Int J Radiat Oncol Biol Phys 1998; 41: 647-50.
    12) Della Biancia C, Hunt M, Furhang E, et al: Radiation treatment planning techniques for lymphoma of the stomach. Int J Radiat Oncol Biol Phys 2005; 62: 745-51.
  • ③ 化学療法と抗体療法
    13) Rohatiner A, d’Amore F, Coiffier B, et al: Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400.
    14) Winter JN, Gascoyne RD, Van Besien K: Low-grade lymphoma. Hematology Am Soc Hematol Educ Program 2004; 203-20. http://asheducationbook.hematologylibrary.org/cgi/reprint/2004/1/203
    15) Hiddemann W, Buske C, Dreyling M, et al: Current management of follicular lymphomas. Br J Haematol 2007; 136: 191-202.
    16) 米国 National Comprehensive Cancer Network(NCCN)の診療ガイドライン(Ver 2. 2009).http:// www.nccn.org/professionals/physician_gls/PDF/nhl.pdf
    17) Thieblemont C: Clinical presentation and management of marginal zone lymphomas. Hematology 2005; 307-313. http://asheducationbook.hematologylibrary.org/cgi/reprint/2005/1/307
    18) Ferrucci PF, Zucca E: Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br J Haematol 2007; 136: 521-38.
    19) Fisher RI, LeBlanc M, Press OW, et al: New treatment options have changed the survival of patients with follicular lymphoma. J Clin Oncol 2005; 23: 8447-52.
    20) Conconi A, Martinelli G, Thiéblemont C, et al: Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003; 102: 2741-5.
    21) Zucca E, Bertoni F, Roggeri E, et al: The gastric marginal zone B-cell lymphoma of MALT type. Blood 2000; 96: 410-9.
    22) Martinelli G, Laszlo D, Ferreri AJ, et al: Clinical activity of rituximab in gastric marginal zone non- Hodgkin’s lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol 2005; 23: 1979-83.
    23) Hammel P, Haioun C, Chaumette M: Efficacy of single-agent chemotherapy in low-grade B-cell mucosaassociated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 1995; 13: 2524-9.
    24) Jäger G, Neumeister P, Brenxinchnek R, et al: Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissure type with cladribine: a phaseⅡ study. J Clin Oncol 2002; 20: 3872-7.
    25) Jäger G, Neumeister P, Quehenberger F, et al: Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phaseⅡ trial. Ann Oncol 2006; 17: 1722-3.
    26) Zinzani PL, Stefoni V, Musuraca G, et al: Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer 2004; 100: 2190-4.
    27) Tobinai K, Watanabe T, Ogura M, et al: PhaseⅡ study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin’s lymphoma. J Clin Oncol 2006; 24: 174-80.
    28) Fabbri A, Lenoci M, Gozzetti A, et al: Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma. Br J Haematol 2007; 139: 90-3.
  • ④ 外科治療
    29) Kodera Y, Yamamura Y, Nakamura S, et al: The role of radical gastrectomy with systematic lymphadenectomy for the diagnosis and treatment of primary gastric lymphoma. Ann Surg 1998; 227: 45-50.
  • [C] びまん性大細胞 B 細胞性リンパ腫の治療
    ① 化学療法,放射線治療
    30) Rohatiner A, d’Amore F, Coiffier B, et al: Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400.
    31) 米国 National Comprehensive Cancer Network(NCCN)の診療ガイドライン(Ver 2. 2009).http:// www.nccn.org/professionals/physician_gls/PDF/nhl.pdf
    32) Fisher RI, Miller TP, O’Connor OA: Diffuse Aggressive Lymphoma. Hematology 2004; 221-236.(ASH educational book)
    33) Coiffier B: State-of-the-art therapeutics: diffuse large B-cell lymphoma. J Clin Oncol 2005; 23: 6387-93.
    34) Ferrucci PF, Zucca E: Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br J Haematol 2007; 136: 521-38.
    35) Coiffier B, Lepage E, Briere J, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-42.
    36)
    Pfreundschuh M, Trümper L, Osterborg A, et al: CHOP-like chemotherapy plus rituximab versus CHOPlike chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Tria(l MInT)Group. Lancet Oncol 2006; 7: 379-91.
    37) The International Non-Hodgkin’s Lymphoma Prognostic Factors Project: A prostpective model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 1993; 329: 987.
    38) Binn M, Ruskoné-Fourmestraux A, Lepage E, et al: Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol 2003; 14: 1751-7.
    39)

    Koch P, Probst A, Berdel WE, et al: Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study(GIT NHL 02/96). J Clin Oncol 2005; 23: 7050-9.
    40) Ishikura S, Tobinai K, Ohtsu A, et al: Japanese multicenter phaseⅡ study of CHOP followed by radiotherapy in stageⅠ-Ⅱ, diffuse large B-cell lymphoma of the stomach. Cancer Sci 2005; 96: 349-52.
    41) Yoon SS, Coit DG, Portlock CS, et al: The diminishing role of surgery in the treatment of gastric lymphoma. Ann Surg 2004; 240: 28-37.
    42) Miller TP, Dahlberg S, Cassady JR, et al: Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin’s lymphoma. N Engl J Med 1998; 339: 21-6.
    43) Horning SJ, Weller E, Kim K, et al: Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin’s lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol 2004; 22: 3032-8.
    44) Bonnet C, Fillet G, Mounier N, et al; Groupe d’Etude des Lymphomes de l’Adulte: CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol 2007; 25: 787-92.
    45) Miller TP, Unger JM, Spier C: Effect of Adding Rituximab to Three Cycles of CHOP Plus Invoved-Field Radiotherapy for Limited-Stage Aggressive Diffuse B-Cell Lymphoma(SWOG-0014). Blood 2004; 104: 158a
    46) Cheson BD, Pfistner B, Juweid ME, et al; The International Harmonization Project on Lymphoma: Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579-86.
    47) Shipp MA, Abeloff MD, Antman KH, et al: International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin’s Lymphomas: report of the jury. J Clin Oncol 1999; 17: 423-9.
  • ② 外科治療
    48) Kodera Y, Yamamura Y, Nakamura S, et al: The role of radical gastrectomy with systematic lymphadenectomy
    for the diagnosis and treatment of primary gastric lymphoma. Ann Surg 1998; 227: 45-50.
    49) Ishikura S, Tobinai K, Ohtsu A, et al: Japanese multicenter phaseⅡ study of CHOP followed by radiotherapy
    in stageⅠ-Ⅱ, diffuse large B-cell lymphoma of the stomach. Cancer Sci 2005; 96: 349-52.